BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 2686911)

  • 1. Serum enzymes in disease of skeletal muscle.
    Rosalki SB
    Clin Lab Med; 1989 Dec; 9(4):767-81. PubMed ID: 2686911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The comparative utility of serum creatine kinase versus serum aldolase in the evaluation of muscle disorders.
    Giesker D; Bowers GN
    Conn Med; 1979 Nov; 43(11):699-704. PubMed ID: 389542
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum creatine phosphokinase in the detection of carriers of Duchenne's muscular dystrophy in Northern Ireland.
    McCormick D; Allen IV
    Ulster Med J; 1976; 45(1):79-83. PubMed ID: 936362
    [No Abstract]   [Full Text] [Related]  

  • 4. Duchenne's muscular dystrophy: carrier detection by muscle ultrasound.
    Rott HD; Mulz D
    J Genet Hum; 1983 Mar; 31(1):63-5. PubMed ID: 6619807
    [No Abstract]   [Full Text] [Related]  

  • 5. [Tests of serum creatine phosphokinase activity in patients with progressive muscular dystrophy and their relatives for the detection of genetic carriers].
    László A; Salgó L
    Orv Hetil; 1981 Jun; 122(24):1453-6. PubMed ID: 7290660
    [No Abstract]   [Full Text] [Related]  

  • 6. The enzymology of skeletal muscle disorders.
    Lott JA; Landesman PW
    Crit Rev Clin Lab Sci; 1984; 20(2):153-90. PubMed ID: 6373145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Present-day clinico-genetic framework of Duchenne's muscular dystrophy].
    Meola G
    Riv Neurol; 1989; 59(1):8-14. PubMed ID: 2669113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of serum pyruvate kinase in patients with Duchenne's muscular dystrophy and carriers. Comparison with other enzyme determinations].
    Calandi C; Adami Lami C; Guidotti T; Nistri R; Papuzza S; Tozzi P; Poggi G
    Minerva Pediatr; 1981 May; 33(10):453-64. PubMed ID: 7254147
    [No Abstract]   [Full Text] [Related]  

  • 9. [Echoscopic diagnosis of the heterozygote carrier state in Duchenne's muscular dystrophy].
    Krasil'nikov VV; Lazebnik TA; Prokof'ev GV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(11):18-9. PubMed ID: 3066080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the simultaneous administration of diethylstilbestrol and prednisolone on serum enzymes in Duchenne's muscular dystrophy.
    Cohen L; Morgan J; Bozyk ME
    J Med; 1977; 8(2):123-34. PubMed ID: 268398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [DNA and dystrophin analysis in Duchenne's and Becker's disease; benefit to the patient].
    Jennekens FG; Ippel PF
    Ned Tijdschr Geneeskd; 1993 Jan; 137(2):61-3. PubMed ID: 8421528
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of carrier detection rates for Duchenne and Becker muscular dystrophies using serum creatine-kinase (CK) and pyruvate-kinase (PK) through discriminant analysis.
    Zatz M; Otto PA
    Am J Med Genet; 1986 Oct; 25(2):219-30. PubMed ID: 3777019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variable effects of corticosteroid treatment of serum enzyme activities in Duchenne's muscular dystrophy.
    Cohen L; Morgan J; Bozyk ME
    Res Commun Chem Pathol Pharmacol; 1977 Jul; 17(3):529-38. PubMed ID: 70832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Critical evaluation of changes of serum CK after exertion in the identification of carriers of Duchenne's muscular dystrophy].
    Cordone G; Venzano V; Rossi G; Cavallero G; Minetti C
    Pediatr Med Chir; 1984; 6(6):819-22. PubMed ID: 6545595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum pyruvate-kinase (PK) activity during pregnancy in potential carriers for Duchenne muscular dystrophy.
    Zatz M; Passos MR; Bortolini ER
    Am J Med Genet; 1983 May; 15(1):149-51. PubMed ID: 6859115
    [No Abstract]   [Full Text] [Related]  

  • 16. [Changes in the activity of blood serum enzymes in relatives of children with myopathy].
    Grinio LP
    Vopr Med Khim; 1966; 12(6):600-3. PubMed ID: 6000902
    [No Abstract]   [Full Text] [Related]  

  • 17. [AMP-aminohydrolase of skeletal muscles in muscular diseases].
    Niebrój-Dobosz I; Strumień M
    Neurol Neurochir Pol; 1979; 13(4):383-7. PubMed ID: 481690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved detection of Duchenne muscular dystrophy heterozygotes using discriminant analysis of creatine kinase levels.
    Muir WA; Knoke J; Martin A; Vignos P; McErlean A
    Am J Med Genet; 1983 Jan; 14(1):125-34. PubMed ID: 6829600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duchenne's muscular dystrophy in six siblings. The case for early diagnosis and neonatal screening.
    Moosa A
    S Afr Med J; 1982 Nov; 62(21):765-7. PubMed ID: 7135141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fetal-blood creatine phosphokinase in the diagnosis of Duchenne's muscular dystrophy.
    N Engl J Med; 1978 Jun; 298(26):1479-80. PubMed ID: 652021
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.